Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,237,303 papers from all fields of science
Search
Sign In
Create Free Account
apolipoprotein B mRNA editing enzyme complex
Known as:
apolipoprotein B mRNA editing enzyme complex location
, apoB mRNA editing enzyme complex
, APOBEC
Expand
Protein complex that mediates editing of the mRNA encoding apolipoprotein B; catalyzes the deamination of C to U (residue 6666 in the human mRNA…
Expand
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2019
Highly Cited
2019
Passenger hotspot mutations in cancer driven by APOBEC3A and mesoscale genomic features
R. Buisson
,
Adam Langenbucher
,
+4 authors
M. Lawrence
Science
2019
Corpus ID: 195750378
APOBEC3A hairpin passenger hotspots Genomic features are often examined at extremes to determine the impact of mutations. These…
Expand
Review
2016
Review
2016
The APOBEC Protein Family: United by Structure, Divergent in Function.
J. Salter
,
R. Bennett
,
HaroldC. Smith
TIBS -Trends in Biochemical Sciences. Regular ed
2016
Corpus ID: 3497843
Highly Cited
2016
Highly Cited
2016
Structural basis for targeted DNA cytosine deamination and mutagenesis by APOBEC3A and APOBEC3B
K. Shi
,
M. Carpenter
,
+11 authors
H. Aihara
Nature Structural &Molecular Biology
2016
Corpus ID: 19830013
APOBEC-catalyzed cytosine-to-uracil deamination of single-stranded DNA (ssDNA) has beneficial functions in immunity and…
Expand
Review
2015
Review
2015
APOBEC Enzymes: Mutagenic Fuel for Cancer Evolution and Heterogeneity.
C. Swanton
,
N. Mcgranahan
,
G. Starrett
,
R. Harris
Cancer Discovery
2015
Corpus ID: 569328
UNLABELLED Deep sequencing technologies are revealing the complexities of cancer evolution, casting light on mutational processes…
Expand
Highly Cited
2014
Highly Cited
2014
APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma
B. Walker
,
C. Wardell
,
+18 authors
G. Morgan
Nature Communications
2014
Corpus ID: 13728858
We have sequenced 463 presenting cases of myeloma entered into the UK Myeloma XI study using whole exome sequencing. Here we…
Expand
Highly Cited
2007
Highly Cited
2007
APOBEC3F Can Inhibit the Accumulation of HIV-1 Reverse Transcription Products in the Absence of Hypermutation
R. K. Holmes
,
F. Koning
,
K. Bishop
,
M. Malim
Journal of Biological Chemistry
2007
Corpus ID: 20117355
APOBEC3F (apolipoprotein B mRNA-editing enzyme catalytic polypeptide 1-like protein 3F) is a cytidine deaminase that, like…
Expand
Highly Cited
2006
Highly Cited
2006
Antiviral Potency of APOBEC Proteins Does Not Correlate with Cytidine Deamination
K. Bishop
,
R. K. Holmes
,
M. Malim
Journal of Virology
2006
Corpus ID: 23324929
ABSTRACT The human cytidine deaminases APOBEC3G (hA3G) and APOBEC3F (hA3F) are intracellular antiretroviral factors that can…
Expand
Highly Cited
2005
Highly Cited
2005
Evolution of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases.
S. Conticello
,
Cornelia J F Thomas
,
Svend K. Petersen-Mahrt
,
M. Neuberger
Molecular biology and evolution
2005
Corpus ID: 23105779
The AID/APOBEC family (comprising AID, APOBEC1, APOBEC2, and APOBEC3 subgroups) contains members that can deaminate cytidine in…
Expand
Highly Cited
2005
Highly Cited
2005
Antiviral Function of APOBEC3G Can Be Dissociated from Cytidine Deaminase Activity
Edmund N. C. Newman
,
R. K. Holmes
,
+4 authors
A. Sheehy
Current Biology
2005
Corpus ID: 16464182
Highly Cited
2004
Highly Cited
2004
Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes: correlation with mutation spectra in vivo.
Rupert C. L. Beale
,
Svend K. Petersen-Mahrt
,
Ian N. Watt
,
R. Harris
,
C. Rada
,
M. Neuberger
Journal of Molecular Biology
2004
Corpus ID: 23676298
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE